Palmitate and inflammatory state additively induce the expression of PTP1B in muscle cells

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 467-471

  Parvaneh, Leila ^a   Meshkani, Reza ^b   Bakhtiyari, Salar ^a   MohammadTaghvaie, Narges ^a   Gorgani Firuzjaee, Sattar ^b   TaheriPak, GholamReza ^b   Golestani, Abolfazl ^b   Foruzandeh, Mehdi ^a   Larijani, Bagher ^c   Taghikhani, Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Free fatty acid; Inflammation; Insulin resistance; Macrophage; Palmitate; Protein tyrosine phosphatase 1B

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; PALMITIC ACID; PROTEIN TYROSINE PHOSPHATASE 1B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; MOUSE; MUSCLE CELL; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77952745052     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.118     Document Type: Article

References (35)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. DeFronzo R.A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37 (1988) 667-687
3. Schenk S., Saberi M., and Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118 (2008) 2992-3002
4. Jove M., Planavila A., Laguna J.C., and Vazquez-Carrera M. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 146 (2005) 3087-3095
5. Jove M., Planavila A., Sanchez R.M., Merlos M., Laguna J.C., and Vazquez-Carrera M. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 147 (2006) 552-561
6. Senn J.J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281 (2006) 26865-26875
7. Dimopoulos N., Watson M., Sakamoto K., and Hundal H.S. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem. J. 399 (2006) 473-481
8. Santomauro A.T., Boden G., Silva M.E., Rocha D.M., Santos R.F., Ursich M.J., Strassmann P.G., and Wajchenberg B.L. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48 (1999) 1836-1841
9. Powell D.J., Turban S., Gray A., Hajduch E., and Hundal H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 382 (2004) 619-629
10. Ahmad F., and Goldstein B.J. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus. Metabolism 44 (1995) 1175-1184
11. Samokhvalov V., Bilan P.J., Schertzer J.D., Antonescu C.N., and Klip A. Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E37-E46
12. Varma V., Yao-Borengasser A., Rasouli N., Nolen G.T., Phanavanh B., Starks T., Gurley C., Simpson P., McGehee Jr. R.E., Kern P.A., and Peterson C.A. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am. J. Physiol. Endocrinol. Metab. 296 (2009) E1300-E1310
13. Arner P., Pollare T., Lithell H., and Livingston J.N. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30 (1987) 437-440
14. Goodyear L.J., Giorgino F., Sherman L.A., Carey J., Smith R.J., and Dohm G.L. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 95 (1995) 2195-2204
15. Dadke S.S., Li H.C., Kusari A.B., Begum N., and Kusari J. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats. Biochem. Biophys. Res. Commun. 274 (2000) 583-589
16. Shi K., Egawa K., Maegawa H., Nakamura T., Ugi S., Nishio Y., and Kashiwagi A. Protein-tyrosine phosphatase 1B associates with insulin receptor and negatively regulates insulin signaling without receptor internalization. J. Biochem. 136 (2004) 89-96
17. Goldstein B.J., Bittner-Kowalczyk A., White M.F., and Harbeck M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem. 275 (2000) 4283-4289
18. Cheyssac C., Lecoeur C., Dechaume A., Bibi A., Charpentier G., Balkau B., Marre M., Froguel P., Gibson F., and Vaxillaire M. Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med. Genet. 7 (2006) 44
19. Meshkani R., Taghikhani M., Mosapour A., Larijani B., Khatami S., Khoshbin E., Ahmadvand D., Saeidi P., Maleki A., Yavari K., Nasoohi N., and Adeli K. 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population. Arch. Med. Res. 38 (2007) 556-562
20. Zabolotny J.M., Haj F.G., Kim Y.B., Kim H.J., Shulman G.I., Kim J.K., Neel B.G., and Kahn B.B. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J. Biol. Chem. 279 (2004) 24844-24851
21. Egawa K., Maegawa H., Shimizu S., Morino K., Nishio Y., Bryer-Ash M., Cheung A.T., Kolls J.K., Kikkawa R., and Kashiwagi A. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J. Biol. Chem. 276 (2001) 10207-10211
22. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., and Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20 (2000) 5479-5489
23. Zinker B.A., Rondinone C.M., Trevillyan J.M., Gum R.J., Clampit J.E., Waring J.F., Xie N., Wilcox D., Jacobson P., Frost L., Kroeger P.E., Reilly R.M., Koterski S., Opgenorth T.J., Ulrich R.G., Crosby S., Butler M., Murray S.F., McKay R.A., Bhanot S., Monia B.P., and Jirousek M.R. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. USA 99 (2002) 11357-11362
24. Ahmad F., Li P.M., Meyerovitch J., and Goldstein B.J. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J. Biol. Chem. 270 (1995) 20503-20508
25. Chen H., Cong L.N., Li Y., Yao Z.J., Wu L., Zhang Z.Y., Burke Jr. T.R., and Quon M.J. A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. Biochemistry 38 (1999) 384-389
26. Ahmad F., Azevedo J.L., Cortright R., Dohm G.L., and Goldstein B.J. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J. Clin. Invest. 100 (1997) 449-458
27. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., and Kahn B.B. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 283 (2008) 14230-14241
28. Nieto-Vazquez I., Fernandez-Veledo S., de Alvaro C., Rondinone C.M., Valverde A.M., and Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 56 (2007) 404-413
29. Shao J., Gao Y., and Yuan Z. Free fatty acids promoting PTP1B expression in rat skeletal muscle and hepatic cells. Zhonghua Yi Xue Za Zhi 78 (1998) 753-755
30. Svedberg J., Bjorntorp P., Smith U., and Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39 (1990) 570-574
31. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., and Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282 (2007) 35279-35292
32. del Aguila L.F., Claffey K.P., and Kirwan J.P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am. J. Physiol. 276 (1999) E849-E855
33. Plomgaard P., Bouzakri K., Krogh-Madsen R., Mittendorfer B., Zierath J.R., and Pedersen B.K. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54 (2005) 2939-2945
34. Lorenzo M., Fernandez-Veledo S., Vila-Bedmar R., Garcia-Guerra L., De Alvaro C., and Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J. Anim. Sci. 86 (2008) E94-E104
35. Nieto-Vazquez I., Fernandez-Veledo S., de Alvaro C., and Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 57 (2008) 3211-3221